LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Diagnostic microbiology and infectious disease

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.diagmicrobio.2012.05.012PMID 22704791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

  2012cited by this paper
• LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United States

  2011influential reference
• Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.

  2010cited by this paper
• Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain.

  2010influential reference
• Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

  2009cited by this paper
• Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

  2009cited by this paper
• Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

  2009cited by this paper
• ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries.

  2009influential reference
• Linezolid surveillance program results for 2008 (LEADER Program for 2008).

  2009influential reference
• Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs.

  2008cited by this paper
• Clinical and Microbiological Aspects of Linezolid Resistance Mediated by the cfr Gene Encoding a 23S rRNA Methyltransferase

  2008cited by this paper
• First Report of cfr-Mediated Resistance to Linezolid in Human Staphylococcal Clinical Isolates Recovered in the United States

  2008cited by this paper
• United States resistance surveillance results for linezolid (LEADER Program for 2007).

  2008influential reference
• Activity of Linezolid against 3,251 Strains of Uncommonly Isolated Gram-Positive Organisms: Report from the SENTRY Antimicrobial Surveillance Program

  2007influential reference
• Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.

  2007cited by this paper
• Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

  2007influential reference
• Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.

  2007cited by this paper
• LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).

  2007influential reference
• The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics

  2006influential reference
• Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.

  2006cited by this paper
• Current antimicrobial resistance profiles among methicillin-resistant Staphylococcus aureus encountered in the outpatient setting.

  2006cited by this paper
• In Vitro Activity of Linezolid against Key Gram-Positive Organisms Isolated in the United States: Results of the LEADER 2004 Surveillance Program

  2005cited by this paper
• Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.

  2005cited by this paper
• Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections

  2005cited by this paper
• Novel Mechanism of Resistance to Oxazolidinones, Macrolides, and Chloramphenicol in Ribosomal Protein L4 of the Pneumococcus

  2005cited by this paper
• Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.

  2005influential reference
• Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.

  2005cited by this paper
• A review of linezolid: the first oxazolidinone antibiotic

  2004cited by this paper
• In Vitro Activities of Telithromycin, Linezolid, and Quinupristin-Dalfopristin against Streptococcus pneumoniae with Macrolide Resistance Due to Ribosomal Mutations

  2004cited by this paper
• Oxazolidinone antibacterial agents: a critical review.

  2003cited by this paper
• Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.

  2003cited by this paper
• Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

  2003cited by this paper
• Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.

  2002cited by this paper
• Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections

  2002cited by this paper
• Oxazolidinone antibiotics.

  2001cited by this paper
• The discovery of linezolid, the first oxazolidinone antibacterial agent.

  2001cited by this paper
• Linezolid: an oxazolidinone antimicrobial agent.

  2001cited by this paper
• Mechanism of action of the oxazolidinone antibacterial agents.

  1999cited by this paper
• In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

  1996cited by this paper
• In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

  1996cited by this paper
• Diagnostic microbiology and therapeutic drug monitoring in pediatric infectious diseases.

  1983cited by this paper

• Oxazolidinones: Mechanism of action and molecular characterization of resistance mechanisms in staphylococci

  2025cites this paper
• Global Occurrence of Linezolid-Resistant Enterococcus (LRE): The First Systematic Review and Meta-Analysis

  2024cites this paper
• The Role of Selected Virulence Factors in Infections Caused by Enterococcus spp.

  2023cites this paper
• Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria

  2021cites this paper
• Antimicrobial Resistance and Virulence Factor Gene Profiles of Enterococcus spp. Isolated from Giant Panda Oral Cavities

  2021influential citation
• Streptogramins for the treatment of infections caused by Gram-positive pathogens

  2020cites this paper
• The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis

  2020cites this paper
• A Study to Comparison of MIC of Linezolid on MRSA by Micro Broth Dilution and E Strip Method in Teaching Hospital, Karnataka

  2020cites this paper
• Antibiotic Consideration in Transplant Recipients

  2019cites this paper
• Emerging Antimicrobial Resistance in Staphylococcus and Spectrum of Oral Oxazolidinone Linezolid in Multidrug Resistant Staphylococcus in a Tertiary Care Hospital

  2019cites this paper
• In vitro efficacy of linezolid against vancomycin resistant Enterococci.

  2018cites this paper
• Isolation of methicillin-resistant Staphylococcus aureus from burn centers and evaluation of antimicrobial efficacy, in Faisalabad, Pakistan

  2018cites this paper
• A high incidence and coexistence of multiresistance genes cfr and optrA among linezolid-resistant enterococci isolated from a teaching hospital in Wenzhou, China

  2018cites this paper
• Linezolid: a promising option in the treatment of Gram-positives

  2017cites this paper
• Atividade antibacteriana de diferentes tipos de veneno de serpentes da família Viperidae contra Staphylococcus aureus

  2017cites this paper
• Resistance to Linezolid

  2017cites this paper
• Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014)

  2016cites this paper
• Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit

  2016cites this paper
• Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014

  2016cites this paper
• Activity of Linezolid when Tested against Gram-Positive Isolates from the USA (Linezolid Experience and Accurate Determination of Resistance [LEADER]) from 2015

  2016cites this paper
• Staphylococcus spp.: an update on the molecular epidemiology and mechanisms of antimicrobial resistance

  2015cites this paper
• Place du linézolide dans la prise en charge de pneumonies nosocomiales à Staphylococcus aureus résistants à la méticilline (SARM)

  2015cites this paper
• Identification and characterization of cfr-positive Staphylococcus aureus isolates from community-onset infectious patients in a county hospital in China.

  2015cites this paper
• In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.

  2015cites this paper
• Individual Pharmacokinetic Characteristics of Treated Patients Is Unrelated to among Enterococci in Intestinal Microbiota The Emergence of Linezolid Resistance

  2014cites this paper
• Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing

  2014cites this paper
• [Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].

  2014cites this paper
• Novel Infectious Diseases and Emerging Gram-Positive Multi-Resistant Pathogens in Hospital and Community Acquired Infections

  2014cites this paper
• Clinical Importance and Epidemiology of Quinolone Resistance

  2014cites this paper
• Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.

  2014cites this paper
• Does vancomycin have a future in the treatment of skin infections?

  2014cites this paper
• Tedizolid for the management of human infections: in vitro characteristics.

  2014cites this paper
• Validation of a Commercial Dry-Form Broth Microdilution Device (Sensititre) for Testing Tedizolid, a New Oxazolidinone

  2014cites this paper
• Resistencia a antibióticos de última línea en cocos Gram positivos: la era posterior a la vancomicina

  2014cites this paper
• of treated patients unrelated to individual pharmacokinetic characteristics.

  2014cites this paper
• The Emergence of Linezolid Resistance among Enterococci in Intestinal Microbiota of Treated Patients Is Unrelated to Individual Pharmacokinetic Characteristics

  2014cites this paper
• Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.

  2014influential citation
• Emergence of mutation‐based linezolid‐resistant invasive Enterococcus faecalis in a haemodialysis patient in Norway

  2014cites this paper
• Clinical Importance and Epidemiology of Quinolone Resistance this access benefits you. Your story matters

  2014cites this paper
• Antimicrobial resistance mechanisms of Staphylococcus aureus

  2013cites this paper
• Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.

  2013cites this paper
• Summary of Linezolid Activity and Resistance Mechanisms Detected during the 2012 LEADER Surveillance Program for the United States

  2013cites this paper
• An international activity and spectrum analysis of linezolid: ZAAPS Program results for 2011.

  2013cites this paper
• Investigational Antimicrobial Agents of 2013

  2013cites this paper
• Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.

  2013cites this paper
• Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.

  2013cites this paper
• Pharmacokinetics of Tedizolid Following Oral Administration: Single and Multiple Dose, Effect of Food, and Comparison of Two Solid Forms of the Prodrug

  2013cites this paper
• Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

  2013cites this paper
• Severe sepsis caused by a linezolid-resistant Enterococcus faecium in a 10-year-old girl after multiple trauma.

  2013cites this paper
• Dissemination of a pSCFS3-Like cfr-Carrying Plasmid in Staphylococcus aureus and Staphylococcus epidermidis Clinical Isolates Recovered from Hospitals in Ohio

  2013cites this paper
• Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada.

  2013cites this paper
• Linezolid Surveillance Results for the United States: LEADER Surveillance Program 2011

  2012cites this paper
• An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy

  2012cites this paper
• Antimicrobials New and Old Molecules in the Fight Against Multi-Resistant Bacteria

  year unknowncites this paper